Recent studies in the Journal of Medical Association (JAMA) and the Journal of American Society of Nephrologists (JASN) point to the potential harmful effects experienced by patients using a popular drug for treating heartburn, known as Prevacid. There has been in an increase in Prevacid lawsuits.
What is Prevacid?
Prevacid is one of the marketing brand names for a class of drugs known as proton pump inhibitors, or PPIs. PPIs work by blocking the stomach from producing stomach acid, in order to decrease the symptoms of heartburn and acid reflux.
What are the risks of taking Prevacid?
One of the side effects of this inhibition of stomach acid being investigated is an increase in infection risk associated with prolonged use of PPIs. Stomach acid, when produced and functioning appropriately, not only helps the body to digest food but also serves as a barrier against bacteria and pathogens that are ingested with food and drink.
With less stomach acid, users of Prevacid are susceptible to infections. Serious pathogens such as Salmonella, Listeria and E. Coli can go undefended against causing illness ranging from minor stomach and intestinal issues to serious system infection. These bacteria can be life-threatening, especially to the elderly, the very young, and those with compromised immune systems.
In addition, with less stomach acid it is harder for the body to digest food properly. In some cases, this can lead to a deficiency in minerals (especially magnesium), vitamins, and the other nutrients a body needs to remain strong and healthy. Prevacid has also been linked to an increased risk of hip fractures for this reason.
Prevacid use in the United States
In the United States, an estimated 15 million people use PPIs. This class of drugs is one of the most commonly prescribed in the U.S. PPIs are available by prescription and over-the-counter under a variety of brand names including Prevacid, Prilosec, and Nexium. While for many years doctors felt these drugs were safe, data is now emerging that suggests this class of drugs may not be as safe as initially determined.
Additionally, the medical community is now presenting evidence that PPIs may be over- prescribed and incorrectly prescribed. Some are suggesting that the prescription guidelines are not followed and patients are put at risk for extremely serious diseases, including an increased risk of chronic kidney disease.
Increase in Prevacid lawsuits
The recent flood of Prevacid lawsuit claiming that manufacturers failed to warn physicians and patients about these increased risks is prompting further investigations. Consumers who have taken any of these brands of PPIs should be vigilant about their health and the potential side effects they may now be encountering from prolonged use of Prevacid. Current users of the drugs may want to consider discussing alternative treatments with their physicians.